Adaptive Biotechnologies Corp (ADPT) returns
Adaptive Biotechnologies returns over 5 years
$1,000 invested in Adaptive Biotechnologies five years ago was worth $797.37 at the close on October 30, 2026, with dividends reinvested: an average return of -4.4% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -7.8% | — | $921.80 | -0.9% |
| 3 months | +10.2% | — | $1,102 | +2.1% |
| Year to date | +64.0% | — | $1,640 | +11.7% |
| 1 year | +57.5% | — | $1,575 | +12.4% |
| 3 years | +515.2% | +83.2% | $6,152 | +88.5% |
| 5 years | -20.3% | -4.4% | $797.37 | +76.0% |
Adaptive Biotechnologies return by calendar year
| Year | ADPT | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +64.0% | +11.7% | +52.4% |
| 2025 | +170.9% | +17.7% | +153.2% |
| 2024 | +22.3% | +24.9% | -2.5% |
| 2023 | -35.9% | +26.2% | -62.1% |
| 2022 | -72.8% | -18.2% | -54.6% |
| 2021 | -52.5% | +28.7% | -81.3% |
| 2020 | +97.6% | +18.4% | +79.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ADPT financials
No forecast, no recommendation. This page describes Adaptive Biotechnologies Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.